Chronic Hepatitis B Antiviral Treatment Indications — free guideline decision tool
This tool judges whether a person with chronic HBV infection meets antiviral treatment indications using HBV DNA, ALT, cirrhosis, and risk factors.
Open guideline tool →Guideline-based
Implements the decision logic from published clinical guidelines.
Runs in your browser
No installation. Enter the patient's values and get a guideline recommendation instantly.
Data stays local
Nothing is uploaded. Results are for licensed clinicians only.
Common questions
What does Chronic Hepatitis B Antiviral Treatment Indications do?
Use to triage to treatment, deferral with follow-up, or no treatment, applying the expanded risk-factor indications of the 2022 Chinese HBV guideline.
How is the result calculated?
Cirrhosis → treat regardless of ALT/DNA. HBV DNA+ with ALT > ULN → treat. HBV DNA+ with normal ALT but family history/age > 30/G≥2 or F≥2/extrahepatic → treat. Otherwise follow up. Drugs: ETV/TDF/TAF.
Is this a substitute for clinical judgement?
No. All results are decision-support only, for licensed clinicians. They must be individualized to the whole patient and the latest guideline version.
Run Chronic Hepatitis B Antiviral Treatment Indications now
This tool judges whether a person with chronic HBV infection meets antiviral treatment indications using HBV DNA, ALT, cirrhosis, and risk factors.
Open guideline tool →For licensed clinicians. Not a substitute for clinical judgement.